Big Pharma Split Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRM.TO research report →
Companywww.harvestportfolios.com/closed-end-funds/big-pharma-split-corp
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector.
- CEO
- Louis Michael Kovacs
- IPO
- 2017
- HQ
- Oakville, ON, CA
Price Chart
Valuation
- Market Cap
- $16.10M
- P/E
- 3.67
- P/S
- -15.58
- P/B
- 0.88
- EV/EBITDA
- 5.35
- Div Yield
- 9.34%
Profitability
- Gross Margin
- 116.63%
- Op Margin
- -388.79%
- Net Margin
- -425.93%
- ROE
- 28.02%
- ROIC
- 12.73%
Growth & Income
- Revenue
- $1.45M · -21.38%
- Net Income
- $4.40M · 916.99%
- EPS
- $3.59 · 863.83%
- Op Income
- $5.03M
- FCF YoY
- 18.56%
Performance & Tape
- 52W High
- $15.50
- 52W Low
- $10.71
- 50D MA
- $13.87
- 200D MA
- $13.27
- Beta
- 0.69
- Avg Volume
- 2.00K
Get TickerSpark's AI analysis on PRM.TO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PRM.TO Coverage
We haven't published any research on PRM.TO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PRM.TO Report →